MEN’S HEALTH MONDAY
 
Bicycle riding: Good or bad for men’s health?
Cycling has multiple benefits, and steps can be taken to prevent genitourinary injury.
Learn more
ADVERTISEMENT
 
Pre-chemo radium-223 does not affect chemo regimens
In a recent study, researchers examined real-world outcomes for patients with metastatic castration-resistant prostate cancer treated with radium-223 (Xofigo). Study author Rana R. McKay, MD, discusses this study and its significance in the castration-resistant prostate cancer landscape.
Read the interview
ADVERTISEMENT
 
Surveillance safe for patients with Grade Group 1 prostate Ca
"Death due to prostate cancer was quite rare, with only four men (0.2%) dying of prostate cancer during the study period," writes Badar M. Mian, MD.
Read his column
SURVEY
 
Is DRE still a relevant tool in the management of prostate cancer?
ADVERTISEMENT
Taking advantage of stones that respond to urine alkalinization
Tim Large, MD, discusses the role of urine alkalinization in treatment for a patient with a staghorn uric acid kidney stone that compromised almost the entire renal pelvis. He shares how alkalinization can reduce stone complexity, cost and morbidity. Watch the case study video now.
 
 
MORE FROM UROLOGY TIMES
 
Hypofractionation noninferior to conventional fractionation for localized PCa
An end to the decline in prostate cancer mortality
 
JOB OPPORTUNITIES
 
NY-WNY Urology Associates
VT-University of Vermont
VT-University of Vermont